US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 6.520
  • +0.270+4.32%
Close Jul 25 16:00 ET
  • 6.520
  • 0.0000.00%
Post 16:08 ET
360.74MMarket Cap-2963P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Foghorn Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

5.05M

-4.88%
EPS(YoY)

-0.59

+19.18%
Analyst Rating

Buy

Jul 10, 2024

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.814M--
--2024/Q2-- / 6.726M--
--2024/Q15.050M / 7.352M--
--2023/Q45.769M / 5.776M--
--2023/Q317.478M / 5.651M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.814M--
--2024/Q2-- / 6.726M--
--2024/Q15.050M / 7.352M--
--2023/Q45.769M / 5.776M--
--2023/Q317.478M / 5.651M--

Unlock Free Earnings Estimates

Foghorn Therapeutics Earnings Reports

  • Foghorn Therapeutics | 10-Q: Quarterly report

    May 6 07:08 ET

  • Foghorn Therapeutics | 10-K: Annual report

    Mar 7 07:14 ET

  • Foghorn Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:08 ET

  • Foghorn Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 4, 2023 07:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 10, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg